Cite
Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study.
MLA
Silva, Wellington F.da, et al. “Outcomes of HIV-Associated Burkitt Lymphoma in Brazil: High Treatment Toxicity and Refractoriness Rates - A Multicenter Cohort Study.” Leukemia Research, vol. 89, Feb. 2020, p. 106287. EBSCOhost, https://doi.org/10.1016/j.leukres.2019.106287.
APA
Silva, W. F. da, Garibaldi, P. M. M., Rosa, L. I. da, Bellesso, M., Clé, D. V., Delamain, M. T., Rego, E. M., Pereira, J., & Rocha, V. (2020). Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study. Leukemia Research, 89, 106287. https://doi.org/10.1016/j.leukres.2019.106287
Chicago
Silva, Wellington F da, Pedro Manoel Marques Garibaldi, Lidiane Inês da Rosa, Marcelo Bellesso, Diego Villa Clé, Márcia Torresan Delamain, Eduardo Magalhães Rego, Juliana Pereira, and Vanderson Rocha. 2020. “Outcomes of HIV-Associated Burkitt Lymphoma in Brazil: High Treatment Toxicity and Refractoriness Rates - A Multicenter Cohort Study.” Leukemia Research 89 (February): 106287. doi:10.1016/j.leukres.2019.106287.